Skip to content

Accuracy of Endo-aid in Consecutive Patients Referred for Colonoscopy

Accuracy of Endo-aid in Consecutive Patients Referred for Colonoscopy - ACCENDO-Colo Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05862948
Acronym
ACCENDO-Colo
Enrollment
1160
Registered
2023-05-17
Start date
2021-10-30
Completion date
2023-04-30
Last updated
2023-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenoma Colon, Colonic Adenoma

Keywords

ADR, CADe, Endo-AID

Brief summary

The goal of this clinical trial is to evaluate the diagnostic yield of CADe in a consecutive population undergoing colonoscopy. The main question it aims to answer is the Adenoma Detection Rate (ADR). Participants undergoing colonoscopy will be randomized in a 1:1 ratio to either receive Computer-Aided Detection (CADe) colonoscopy or a conventional colonoscopy (CC). Researchers will compare the CADe group and the CC-group to see if CAD-e can increase the ADR significantly.

Interventions

DEVICEENDO-Aid by Olympus

Colonoscopy assisted by ENDO-AID device

Sponsors

Fondazione Poliambulanza Istituto Ospedaliero
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years or ≤85 * Patients undergoing screening, follow-up, or diagnostic colonoscopy

Exclusion criteria

* Suspected or known inflammatory bowel disease * Colonic resection * Taking anticoagulants or antiaggregants that contraindicate the performance of therapy * Patients with incomplete colonoscopy * Patients with inadequate preparation using the Boston Colonic Preparation Scale (BBPS). A cleaning quality of less than 2 points in any of the 3 colonic sections will be considered inadequate. * Inability to provide informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Adenoma detection rate (ADR)1 yearsADR defined as the proportion of patients with at least 1 adenoma detected.

Secondary

MeasureTime frameDescription
Polyp detection rate (PDR)1 yearsPDR defined as the proportion of patients with at least 1 polyp detected.
Polyp per colonoscopy (PPC)1 yearsPPC defined as total number of polyps resected divided by the total number of colonoscopies.
Adenoma per colonoscopy (APC)1 yearsAPC defined as total number of histologically confirmed adenomas resected divided by the total number of colonoscopies.
Sessile serrated lesion detection rate (SSLDR)1 yearsSSLDR percentage of patients who have 1 or more histologically confirmed sessile serrated lesion resected divided by the total number of colonoscopies.
Advanced adenoma detection rate (AADR)1 yearsAADR Adenomas are classified as advanced with a size \>= 10mm and/or a (tubulo)villous histology and/or high-grade dysplasia (HGD)

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026